Canopy Growth (CGC)
(Delayed Data from NSDQ)
$7.59 USD
+0.27 (3.69%)
Updated Jun 12, 2024 04:00 PM ET
After-Market: $7.58 -0.01 (-0.13%) 7:58 PM ET
3-Hold of 5 3
D Value A Growth F Momentum C VGM
Brokerage Reports
Canopy Growth Corporation [CGC]
Reports for Purchase
Showing records 1 - 20 ( 74 total )
Company: Canopy Growth Corporation
Industry: Medical - Products
Company: Canopy Growth Corporation
Industry: Medical - Products
Best Canadian Exposure to U.S. Regulatory Changes
Provider: Roth Capital Partners, Inc.
Analyst: KIRK W
Company: Canopy Growth Corporation
Industry: Medical - Products
Company: Canopy Growth Corporation
Industry: Medical - Products
Company: Canopy Growth Corporation
Industry: Medical - Products
Cannabis Industry Update: 3Q23 Performance Valuations
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Canopy Growth Corporation
Industry: Medical - Products
Company: Canopy Growth Corporation
Industry: Medical - Products
Company: Canopy Growth Corporation
Industry: Medical - Products
Company: Canopy Growth Corporation
Industry: Medical - Products
Weekly ReHash: Price Deflation a Needed Market Dynamic to Convert Illicit Mkt
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Canopy Growth Corporation
Industry: Medical - Products
Company: Canopy Growth Corporation
Industry: Medical - Products
Company: Canopy Growth Corporation
Industry: Medical - Products
Company: Canopy Growth Corporation
Industry: Medical - Products
Weekly ReHash: Early Readthrough Into 1Q22 Confirms Industry Headwinds
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Canopy Growth Corporation
Industry: Medical - Products
Industry 1Q22 Preview: Near-Term Softness on Consumer Headwinds, 2H22 Pick Up
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Canopy Growth Corporation
Industry: Medical - Products
Consumer Weekly ReHash: Assessing 4Q21 Reports & Resetting 2022 Guidance/Outlook
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Canopy Growth Corporation
Industry: Medical - Products
Weekly ReHash: Israel - Pioneering Cannabis into a Large Market Opportunity
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Canopy Growth Corporation
Industry: Medical - Products
Weekly ReHash: Cannabis SPACs Underperformed in 2021, Reset
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Canopy Growth Corporation
Industry: Medical - Products
Company: Canopy Growth Corporation
Industry: Medical - Products
Company: Canopy Growth Corporation
Industry: Medical - Products
Weekly ReHash: California To See Lots of Changes in 2022, Positive Developments
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S